ArticleCurrent neuropharmacology2013

Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy.

Roxanna Perez-Garmendia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.